Somasundaram, Rajasekharan
Connelly, Thomas
Choi, Robin
Choi, Hyeree
Samarkina, Anastasia http://orcid.org/0000-0003-1553-4366
Li, Ling
Gregorio, Elizabeth
Chen, Yeqing
Thakur, Rohit
Abdel-Mohsen, Mohamed
Beqiri, Marilda
Kiernan, Meaghan
Perego, Michela http://orcid.org/0000-0002-5671-928X
Wang, Fang
Xiao, Min
Brafford, Patricia
Yang, Xue
Xu, Xiaowei
Secreto, Anthony
Danet-Desnoyers, Gwenn
Traum, Daniel
Kaestner, Klaus H.
Huang, Alexander C.
Hristova, Denitsa
Wang, Joshua http://orcid.org/0000-0002-9949-798X
Fukunaga-Kalabis, Mizuho
Krepler, Clemens
Ping-Chen, Fang
Zhou, Xiangyang
Gutierrez, Alexis
Rebecca, Vito W.
Vonteddu, Prashanthi
Dotiwala, Farokh http://orcid.org/0000-0002-7387-2219
Bala, Shashi
Majumdar, Sonali
Dweep, Harsh
Wickramasinghe, Jayamanna
Kossenkov, Andrew V.
Reyes-Arbujas, Jorge
Santiago, Kenisha
Nguyen, Tran
Griss, Johannes http://orcid.org/0000-0003-2206-9511
Keeney, Frederick
Hayden, James
Gavin, Brian J.
Weiner, David http://orcid.org/0000-0002-2232-8512
Montaner, Luis J. http://orcid.org/0000-0001-5799-6759
Liu, Qin http://orcid.org/0000-0001-9964-580X
Peiffer, Lukas http://orcid.org/0000-0003-3729-2249
Becker, Jürgen
Burton, Elizabeth M.
Davies, Michael A. http://orcid.org/0000-0002-0977-0912
Tetzlaff, Michael T.
Muthumani, Kar http://orcid.org/0000-0002-6807-2065
Wargo, Jennifer A. http://orcid.org/0000-0003-3438-7576
Gabrilovich, Dmitry http://orcid.org/0000-0001-9913-6407
Herlyn, Meenhard
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P50 CA174523, U54 CA224070, CA010815)
U.S. Department of Defense (PRCRP WX1XWH-16-1-0119 [CA150619], W81XWH-16-1-0120 and W81XWH-16-1-0121)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 16 April 2020
Accepted: 10 December 2020
First Online: 12 January 2021
Competing interests
: M.A.D. has been a consultant to Roche/Genentech, Array, Novartis, BMS, GSK, Sanofi-Aventis, Vaccinex, and Apexigen, and he has been the PI of research grants to MD Anderson by Roche/Genentech, GSK, Sanofi-Aventis, Merck, Myriad, and Oncothyreon. M.T.T. has advisory board relationships with Nanostring, Merck, Bristol Meyers, and Myriad Genetics. J.A.W. serves as a consultant/advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol-Myers Squibb, Merck, Biothera Pharmaceuticals and Microbiome DX., and has research support from GlaxoSmithKline, Roche/Genentech, Bristol-Myers Squibb, and Novartis. The remaining authors declare no competing interests.